AZ commits £28m to tackle non-communicable disease
The plan is designed to inform adolescents in under-resourced communities on how to reduce risky behaviours including smoking, alcohol, poor diet and lack of exercise.
Read More
Tag: global
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
